Kiniksa Pharmaceuticals International, plc
KNSA나스닥Pharmaceutical PreparationsUS미국
30일 공시 수
3건
최근 2026.10.28
90일 내부자 순매수
0원
변동 없음
보유 기관 수
—
준비 중
다음 예정 이벤트
—
준비 중
총 9건
- US미국정기보고서중요도 보통6일 전10-Q · Quarterly report
Kiniksa Pharmaceuticals International, plcKNSA
10-Q · 2026.10.28 05:36 KST
- US미국실적중요도 보통7일 전8-K · Current report (Items 2.02, 9.01)
Kiniksa Pharmaceuticals International, plcKNSA
8-K · 2026.10.27 20:32 KST
- US미국지배구조·주총중요도 보통2026.10.238-K · Current report (Items 5.02)
Kiniksa Pharmaceuticals International, plcKNSA
8-K · 2026.10.23 05:28 KST
- US미국임원·주요주주 소유중요도 낮음2026.09.034 · Statement of changes in beneficial ownership
Kiniksa Pharmaceuticals International, plcKNSA
Form 4 · 2026.09.03
- US미국임원·주요주주 소유중요도 낮음2026.09.034 · Statement of changes in beneficial ownership
Kiniksa Pharmaceuticals International, plcKNSA
Form 4 · 2026.09.03
- US미국임원·주요주주 소유중요도 낮음2026.09.034 · Statement of changes in beneficial ownership
Kiniksa Pharmaceuticals International, plcKNSA
Form 4 · 2026.09.03
- US미국임원·주요주주 소유중요도 낮음2026.09.034 · Statement of changes in beneficial ownership
Kiniksa Pharmaceuticals International, plcKNSA
Form 4 · 2026.09.03
- US미국임원·주요주주 소유중요도 낮음2026.09.034 · Statement of changes in beneficial ownership
Kiniksa Pharmaceuticals International, plcKNSA
Form 4 · 2026.09.03
- US미국임원·주요주주 소유중요도 낮음2026.09.034 · Statement of changes in beneficial ownership
Kiniksa Pharmaceuticals International, plcKNSA
Form 4 · 2026.09.03